Bloomberg Law
Free Newsletter Sign Up
Bloomberg Law
Free Newsletter Sign Up

Patients Get Direct Insulin, Epinephrine Discounts in New Rule

Dec. 22, 2020, 3:26 PM

Certain health centers must pass discounts they get on insulin and epinephrine directly to their patients under a rule finalized Tuesday.

The rule applies to some federally funded health centers and is meant to cut costs for low-income patients who struggle to afford their medications. Those centers risk losing federal grants if they don’t comply.

The rule targets facilities that buy steeply discounted drugs through a federal discount program called 340B. Patients that make up to $44,000 a year, are uninsured, or have high deductibles or copays are eligible for the discounts, according to the rule.

Critics of the plan, ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.